Cargando…
Streptokinase in a COVID-19-positive patient with STEMI in a PPCI centre: a local experience
Primary percutaneous coronary intervention is the recommended modality of treatment for acute ST-elevation myocardial infarction (STEMI). However, different countries now have different consensus about treatment of patients with STEMI during the COVID-19 pandemic. In this report, we describe a case...
Autores principales: | Rahman, Nasir, Ullah, Ihsan, Adnan, Ghufran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839887/ https://www.ncbi.nlm.nih.gov/pubmed/33495187 http://dx.doi.org/10.1136/bcr-2020-239068 |
Ejemplares similares
-
Activation of PPCI team in the octogenarian and nonagenarians population: real-world single-centre experience
por: Kumar, Rajesh, et al.
Publicado: (2021) -
No-Reflow after PPCI—A Predictor of Short-Term Outcomes in STEMI Patients
por: Pantea-Roșan, Larisa Renata, et al.
Publicado: (2020) -
Comparison of Different Risk Scores for Prediction of In-Hospital Mortality in STEMI Patients Treated with PPCI
por: Wang, Chih-Hwa, et al.
Publicado: (2022) -
The impact of systems-of-care on pharmacoinvasive management with streptokinase: The subgroup analysis of the TN-STEMI programme
por: Raja, Deep Chandh, et al.
Publicado: (2017) -
Assessment of stess and rest perfusion in patients early after first anterior STEMI patients treated successfully with pPCI
por: Piotrowska-Kownacka, Dorota, et al.
Publicado: (2009)